Biotech Values

[DewDiligence]

More market-share figures for US HIV market:

>Do you happen to know the fraction of the HIV market which involves treatment-naive patients?<

I assume you’re asking about the US market, specifically. It’s about 1/3 treatment-naïve and 2/3 treatment-experienced.

Referring to the color codes in the pie chart in #msg-25102913, the corresponding market shares in the treatment-experienced setting are roughly as follows: orange 5%, maroon 40%, yellow 45%, green 10%.

Using the same color codes, the overall number of patients in the US HIV market are approximately: orange 120K, maroon 170K, yellow 180K, green 40K. Total US market 510K patients.

Regards, Dew